Pulmonary Fibrosis : A Type Of Disease

PHYSICAL EXAM: Temperature 98.6, Blood pressure 140/90. Pulse 110. Respirations 26. Her lungs are clear, showing mild signs of distress. Heart sounds are normal, irregular rhythm and bradycardia noted. No edema noted in extremities. Patient skin is cool to touch, slightly clammy. EEG shows prolonged QRS wave, with ischemic ST changes and PVCs. Chest radiograph clear.

States that it started 3 days back and uses oxygen at home. States that he is a former smoker and laying on his back feels better. Also says he has a list of medication, more than 20. Pt has a history of COPD, CHF, DM,morbid obesity, HTN, HLM, hypothyroid, and sleep apnea. Has no accessory muscle use. CC is shortness of breath. Assessment is that there is no deformities or trauma of the head or neck area. Chest shows no signs of deformities or trauma. The abdominal area is tender and warm to the touch. Pelvis and back was not assessed. The upper and lower extremities show signs of low circulation and swelling. PMS=4. I helped with placing the BP cuff on the left arm and attaching it to the monitor. First vitals were recorded. O2 was given by the Nurse and then Albuterol by nebulizer. After 30 minutes, I assisted the Nurse and other hospital workers in moving the PT to a bigger bed. Second set of vitals were recorded. After becoming stable the Pt was moved up to the floor.

Idiopathic pulmonary fibrosis (IPF) is a progressive, debilitating and life-threatening, interstitial lung disease of unknown etiology that has no cure (1). The median survival of patients with IPF is only 2 to 3 years. Respiratory failure resulting from this disease progression is the most frequent cause of death. Continuous damage to the alveolar epithelium and concomitant alveolar type II (ATII) cell apoptosis are thought to lead to fibroblast recruitment, accumulation and proliferation and contribute to the perpetuation of the fibrotic scarring and IPF development. ATII cells synthesize, store, and secrete

The categories of the health history addressed are name- H.M., age- 68, gender- female, race- white, reason for seeking care-seven days of exceptional shortness of breath and increased volume of sputum, and awakens two or three times per night coughing and short of breath, which turned a greenish color, present health-COPD exacerbation, past health-Had three or four bouts of bronchitis in the past year that she treated at home, 30-pack-year history of smoking; smokes half a pack per day now to “clear out lungs” in the morning, cannot climb one flight of stairs without stopping; walks down the flat driveway 10 yards without difficulty. The categories that have not been addressed are allergies, current medications, family history, and complete review of systems.

Cystic Fibrosis is a genetic disease that has been found to be life threatening. It causes buildup of mucus in the lungs and in other organisms. In the lungs, mucus can get so built up that it blocks the airway and can lead to infection and possibly lung failure.

I remember this case as today, because he was so young, but my grandfather felt betrayed and that he was losing his time and medication with this patient. My grandfather stood up, was hearing his heart with a stethoscope, and one indication for him to hear

Idiopathic pulmonary fibrosis is a horrible and ultimately fatal chronic lung disease in men and women. Characterized by irreversible loss of lung function, patients that are diagnosed are usually only given about 4 years to live. Although the cause of Idiopathic pulmonary fibrosis is still unknown, there are several risk factors involved. The symptoms of idiopathic pulmonary fibrosis are not specific, and are similar to many other types of pulmonary cardiac diseases. The majority of people with the disease have about a 6-month or more history of shortness of breath and/or nonproductive cough. About 5% of people with idiopathic pulmonary fibrosis do not have symptoms, and the disease is diagnosed when he or she is being examined for other medical

Idiopathic pulmonary fibrosis (IPF) is a fatal irreversible disease that severely diminishes lung function. IPF is part of a 200 + lung disease group known as interstitial lung diseases (ILD). The ILD group of diseases adversely affects the interstitium, which is the interstitial space between the lung tissue and air sacs. IPF is characterized by the scarring and honeycombing of the lung tissue and the accretion of fibrosis. The word 'idiopathic' is derived from the Greek word ‘idios’, which means 'of unknown cause' and aptly explain the status of the prognosis of this deadly disease. Some of the symptoms of IPF is shortness of breath (dyspnea), crackling sound in the lungs, finger clubbing and unrelenting dry cough.

LAM lung disease, also known as lymphangioleiomyomatosis, is a rare degenerative disease. LAM was first discovered in the early 1990’s. Because the symptoms of LAM so closely relates to symptoms such as asthma and emphysema, the disease took some time to develop medical opinion. In 1994, a particular event took place to create an official organization to battle the new disease. After LAM was officially diagnosed in Sue Byre’s 22-year old daughter, she launched the LAM Foundation in 1995 and dedicated her time and funds to researching the growing threat. LAM is almost exclusively found in women, with only four reported cases found within men. There are confirmed diagnoses of 2,000 women, with an estimate of as many as 300,000 women worldwide

A second medical nutrition diagnosis of Idiopathic Pulmonary Fibrosis is and inability or lack of desire to manage self-care. Once IPF progresses, patients gradually lose ability to care for themselves. Additionally, many patients often become depressed causing them to suffer with a lack of desire to care for themselves or to be cared for (National Institutes of Health, 2011). These are usually patients without an adequate support system. As a result, many IPF patients are given the nutrition diagnosis, inability or lack of desire to manage self-care. This can be improved by the aid of either a spouse or family member, or even a nurse. Exercise is one self-care activity that IPF patients gradually lose control of. This can be improved by keeping

Pulmonary fibrosis is a subset of interstitial lung disease (ILD), a general category that includes various lung conditions. These disorders affect the absorption of oxygen into the lungs and impede normal breathing. Pulmonary fibrosis, like other interstitial lung diseases, affect the interstitium, the lace-like network of tissues that provides support to the lungs’ tiny air sacs, or alveoli. Tiny blood vessels travel through the interstitium, allowing gas exchange between the blood and lungs. Normally, the interstitium is too delicate to be seen in a chest x-ray or CT scan, but interstitial lung diseases like pulmonary fibrosis cause the interstitium to thicken due to scarring, extra fluid or inflammation. If you suspect you or someone you

Emphysema: Emphysema is chronic lung disease, which lasts in the long-term. The air sacs, also known as the alveoli in the lungs are damaged. When the air sacs are damaged, their size increases. Less oxygen is carried to the blood. The result of this is shortness of breathing which gets worse

As we know that pulmonary fibrosis is a restrictive disease. People who are suffered from pulmonary fibrosis lives a difficult life as they have trouble taking air in to the lungs. The major symptom related to this disease is dyspnea. In common terms, pulmonary fibrosis is considered as scarring in the lungs. The scar in the lungs makes it difficult for oxygen to get into the blood. It also makes difficult for the patient to feel short of breath especially during exercise or walking. I support the idea of pulmonary rehabilitation to improve quality of life and strengthen muscles. It was a great review to know about different oxygen cylinders. I have never changed the regulator of H cylinder, but I would definitely want to learn about it. I

1. Lung disease is the fourth leading cause of death in the United States. Technically any disease or disorder in which lung function is impaired is considered a lung disease. Some common respiratory diseases are Bronchitis, asthma, allergies, and hay fever. First, bronchitis is is an inflammation of the lining of the bronchial tubes, and less air is able to flow into the lungs, and mucus begins to form. This disease is usually come the environment, such as inhaling certain chemicals, cigarette smoke, fumes from hairspray. Prescription drugs can reduce inflammation, prevent music buildup, and stop bacterial infections. Next is asthma. It is a long-term, chronic inflammatory disorder that blocks airflow into and out of the lungs. Symptoms include

When a non-smoker gets pulmonary fibrosis, it’s generally considered idiopathic pulmonary fibrosis, a form with no known cause. Pulmonary fibrosis is a progressive disease that varies in the rate of degeneration from person to person. Scarring of the lungs is irreversible.